title: Spinal cord disease due to melioidosis.
authors.affiliation: Royal Brisbane Hospital, Department of Medicine, University of Queensland, Australia.
authors.forename: P P
authors.initials: PP
authors.lastname: Bartley
authors.forename: M P
authors.initials: MP
authors.lastname: Pender
authors.forename: M L
authors.initials: ML
authors.lastname: Woods
authors.forename: D
authors.initials: D
authors.lastname: Walker
authors.forename: J A
authors.initials: JA
authors.lastname: Douglas
authors.forename: A M
authors.initials: AM
authors.lastname: Allworth
authors.forename: D P
authors.initials: DP
authors.lastname: Eisen
authors.forename: B J
authors.initials: BJ
authors.lastname: Currie
mesh_terms: D000328:Adult; D001921:Brain / Q000473:pathology; D016957:Burkholderia pseudomallei; D002442:Ceftazidime / Q000008:administration & dosage; D002511:Cephalosporins / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008554:Melioidosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D013116:Spinal Cord / Q000473:pathology; D013118:Spinal Cord Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage
chemical_list: D002511:Cephalosporins; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002442:Ceftazidime